Kilitch Drugs (India) Buy Hold or Sell Recommendation
| KILITCH Stock | 336.20 15.25 4.75% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Kilitch Drugs Limited is 'Cautious Hold'. The recommendation algorithm takes into account all of Kilitch Drugs' available fundamental, technical, and predictive indicators you will find on this site.
Check out Kilitch Drugs Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Kilitch and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Kilitch Drugs Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Kilitch |
Execute Kilitch Drugs Buy or Sell Advice
The Kilitch recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Kilitch Drugs Limited. Macroaxis does not own or have any residual interests in Kilitch Drugs Limited or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Kilitch Drugs' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Insignificant | Details | |
Volatility | Very steady | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Very Small | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Kilitch Drugs Trading Alerts and Improvement Suggestions
| Kilitch Drugs is unlikely to experience financial distress in the next 2 years | |
| Kilitch Drugs Limited has accumulated about 1.34 M in cash with (56.69 M) of positive cash flow from operations. | |
| Roughly 75.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Kilitch Drugs Reports Strong Sales Growth Amidst Mixed Financial Indicators and Market Sentiment - MarketsMojo |
Kilitch Drugs Returns Distribution Density
The distribution of Kilitch Drugs' historical returns is an attempt to chart the uncertainty of Kilitch Drugs' future price movements. The chart of the probability distribution of Kilitch Drugs daily returns describes the distribution of returns around its average expected value. We use Kilitch Drugs Limited price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Kilitch Drugs returns is essential to provide solid investment advice for Kilitch Drugs.
| Mean Return | 0 | Value At Risk | -3.03 | Potential Upside | 4.47 | Standard Deviation | 2.07 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Kilitch Drugs historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Kilitch Drugs Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | 19.7M | (14.1M) | 29.6M | (19.4M) | (22.3M) | (21.2M) | |
| Change In Cash | 97.0M | (24.4M) | 133.4M | (8.8M) | (10.2M) | (9.7M) | |
| Free Cash Flow | 93.6M | (24.2M) | 23.2M | (121.2M) | (139.4M) | (146.3M) | |
| Depreciation | 19.9M | 24.7M | 35.5M | 33.5M | 30.1M | 32.6M | |
| Other Non Cash Items | 5.7M | (11.1M) | 19.0M | (40.6M) | (46.7M) | (49.0M) | |
| Capital Expenditures | 363.0M | 82.0M | 2.6M | 64.5M | 58.1M | 106.0M | |
| Net Income | 51.2M | 96.1M | 120.1M | 193.5M | 174.2M | 182.9M | |
| End Period Cash Flow | 125.0M | 100.6M | 234.0M | 189.6M | 218.1M | 229.0M | |
| Investments | (2.7M) | (69.3M) | 114.7M | (95.4M) | (85.9M) | (81.6M) | |
| Net Borrowings | 31.6M | 21.9M | 25M | 17.6M | 20.3M | 21.1M | |
| Change To Netincome | (38.7M) | 20.9M | 19.8M | 43.1M | 49.6M | 52.1M |
Kilitch Drugs Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Kilitch Drugs or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Kilitch Drugs' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Kilitch stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.02 | |
β | Beta against Dow Jones | 0.25 | |
σ | Overall volatility | 2.22 | |
Ir | Information ratio | 0.04 |
Kilitch Drugs Volatility Alert
Kilitch Drugs Limited has relatively low volatility with skewness of 0.49 and kurtosis of 1.01. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Kilitch Drugs' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Kilitch Drugs' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Kilitch Drugs Fundamentals Vs Peers
Comparing Kilitch Drugs' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Kilitch Drugs' direct or indirect competition across all of the common fundamentals between Kilitch Drugs and the related equities. This way, we can detect undervalued stocks with similar characteristics as Kilitch Drugs or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Kilitch Drugs' fundamental indicators could also be used in its relative valuation, which is a method of valuing Kilitch Drugs by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Kilitch Drugs to competition |
| Fundamentals | Kilitch Drugs | Peer Average |
| Return On Equity | 0.0832 | -0.31 |
| Return On Asset | 0.0566 | -0.14 |
| Profit Margin | 0.11 % | (1.27) % |
| Operating Margin | 0.14 % | (5.51) % |
| Current Valuation | 4.91 B | 16.62 B |
| Shares Outstanding | 16.08 M | 571.82 M |
| Shares Owned By Insiders | 75.15 % | 10.09 % |
| Price To Book | 2.73 X | 9.51 X |
| Price To Sales | 2.90 X | 11.42 X |
| Revenue | 1.54 B | 9.43 B |
| Gross Profit | 808.42 M | 27.38 B |
| EBITDA | 286.33 M | 3.9 B |
| Net Income | 193.54 M | 570.98 M |
| Cash And Equivalents | 1.34 M | 2.7 B |
| Total Debt | 316.46 M | 5.32 B |
| Book Value Per Share | 117.76 X | 1.93 K |
| Cash Flow From Operations | (56.69 M) | 971.22 M |
| Earnings Per Share | 12.13 X | 3.12 X |
| Target Price | 466.0 | |
| Number Of Employees | 168 | 18.84 K |
| Beta | 0.18 | -0.15 |
| Market Capitalization | 5.27 B | 19.03 B |
| Total Asset | 2.4 B | 29.47 B |
| Retained Earnings | 842.33 M | 9.33 B |
| Working Capital | 817.77 M | 1.48 B |
| Net Asset | 2.4 B |
Kilitch Drugs Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Kilitch . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 2465.02 | |||
| Daily Balance Of Power | 0.8449 | |||
| Rate Of Daily Change | 1.05 | |||
| Day Median Price | 329.98 | |||
| Day Typical Price | 332.05 | |||
| Market Facilitation Index | 4.0E-4 | |||
| Price Action Indicator | 13.85 | |||
| Period Momentum Indicator | 15.25 |
About Kilitch Drugs Buy or Sell Advice
When is the right time to buy or sell Kilitch Drugs Limited? Buying financial instruments such as Kilitch Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Kilitch Drugs in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Investing Thematic Idea Now
Investing
Companies involved in money management and investment banking services. The Investing theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Investing Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Kilitch Stock
Kilitch Drugs financial ratios help investors to determine whether Kilitch Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kilitch with respect to the benefits of owning Kilitch Drugs security.